Sunset Capital Assets, Inc. (SNST)
| Market Cap | 26.59K |
| Revenue | n/a |
| Net Income | n/a |
| Shares Out | 265.92M |
| EPS | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,650 |
| Average Volume | 14,364 |
| Open | 0.0001 |
| Previous Close | n/a |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | 0.0000 - 0.0001 |
| Beta | -18.94 |
| RSI | 39.17 |
| Earnings Date | n/a |
About Sunset Capital Assets
Aphex BioCleanse Systems, Inc. develops sanitizing solutions without the use of alcohol. It products includes sanitizers, surface disinfectants, wound wash, and solutions for treatment of livestock. The company was incorporated in 2010 and is based in Rochester, New York. [Read more]
News
Aphex BioCleanse Systems Inc Announces It Has Filed A Debtor In Possession Plan In The Florida Middle District Bankruptcy Court
Venice, FL, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST), which had filed a voluntary petition under the Federal Bankruptcy Code, Chapter 11, Subchapter V with the Pe...
Aphex BioCleanse Systems Inc Files for Bankruptcy Protection under Chapter 11, Subchapter V
Venice, FL, May 19, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST), has filed a voluntary petition under the Federal Bankruptcy Code, Chapter 11, Subchapter V. The Petition was ...
Aphex BioCleanse System Inc Suspends Director Scott Smith
PITTSFORD, NY, March 04, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST), a forward-thinking, publicly-traded company, announces the Board of Directors of Aphex BioCleanse System...